The cost of drugs in the U.S. continues to skyrocket. The average drug price increase from 2022 to 2023 was 15%, according to ...
Several drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical companies that it alleges are ...
"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given ...
The Federal Trade Commission (“FTC”) and the Antitrust Division of the Department of Justice (“DOJ”) announced on Thursday, May 23, that they are expanding their search for businesses using “roll up” ...
The cost of drugs in the U.S. continues to skyrocket. The average drug price increase from 2022 to 2023 was 15%, according to ...